2G

Description 

Research Peptide: Tirzepatide 21 mg
Only for use in laboratory research. Not for ingestion by humans.
With a C20 fatty diacid chain added for extended activity, tirzepatide is a synthetic 39-amino-acid dual (2G) agonist peptide of the GLP-1 and GIP receptors. Preclinical studies on obesity, glycemic management, insulin sensitivity, and metabolic health employ this 10 mg lyophilized formulation because it provides high purity (HPLC validated).
Important applications for research:
Studies on dual GLP-1 and GIP receptor activation
Important studies on body composition and weight loss
Studies on satiety signaling and appetite suppression
Models of insulin sensitivity and glucose regulation Tirzepatide 21 mg is the research peptide.
Use only for research in the lab. Not for human consumption.
Tirzepatide is a synthetic 39-amino-acid dual (2G) agonist peptide of the GLP-1 and GIP receptors that has a C20 fatty diacid chain added for prolonged activity. This 10 mg lyophilized formulation is used in preclinical research on obesity, glycemic control, insulin sensitivity, and metabolic health due to its high purity (HPLC confirmed).
Significant uses for research:
Research on the dual activation of GLP-1 and GIP receptors
Significant research on weight loss and body composition
Research on appetite suppression and satiety signaling
Insulin sensitivity and glucose regulation models